Back to BlackRock, Inc. BlackRock, Inc.

GLTOGLTO
7 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in DAMORA THERAPEUTICS INC

BlackRock, Inc. holds 3.2M shares of GLTO (DAMORA THERAPEUTICS INC), worth $82.2M as of 2026-Q2. The position was increased (+1321.6% shares). GLTO represents 0.0% of BlackRock, Inc.'s portfolio.

Current Value

$82.2M

Current Shares

3.2M

Total Value Change

+$82.2M

Total Shares Change

+3.2M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
3.2M
+1321.6%
$82.2M0.0%$28.08
48
2026-Q1
Increased
222,437
+2857.9%
$5.8M0.0%$28.08
44
2025-Q4
Increased
7,520
+7420.0%
$173,0350.0%$22.31
25
2025-Q3
Unchanged
100
0.0%
$3720.0%$3.80
0
2025-Q2
Decreased
100
-79.6%
$3410.0%$3.42
0
2025-Q1
Unchanged
490
0.0%
$1,5190.0%$3.42
0
2024-Q4
New
490
-
$2,2790.0%$4.60
18

Other major holders of GLTO: FMR LLC, Avoro Capital Advisors LLC, RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used